Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE)

Autor: Peter Junker, R. G. Q. Leslie, Anders Jørgen Svendsen, S E Svehag, J M Rasmussen, Claus Henrik Nielsen, H. V. Marquart

Publikováno v: Marquart, H V, Svendsen, A J, Rasmussen, J M, Nielsen, C H, Junker, P, Svehag, S E & Leslie, R G 1995, ' Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE) ', Clinical and Experimental Immunology, vol. 101, no. 1, pp. 60-65 . https://doi.org/10.1111/j.1365-2249.1995.tb02277.x

It has previously been reported that the expression of the complement receptors, CR1 on erythrocytes and blood leucocytes and CR2 on B cells, is reduced in patients with SLE, and that the reduced expression of CR1 on erythrocytes is related to diseas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d357f8e8866370f37faba8fe092be163
https://doi.org/10.1111/j.1365-2249.1995.tb02277.x

CR2 is the primary acceptor site for C3 during alternative pathway activation of complement on human peripheral B lymphocytes

Autor: H V Marquart, S E Svehag, R G Leslie

Publikováno v: The Journal of Immunology. 153:307-315

Human cells infected with certain viruses acquire the ability to activate the alternative pathway (AP) of complement. Complement receptor 2 on EBV-infected lymphoblastoid cell lines has been reported to act as the covalent binding site for C3b during

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::091c639161673dc7abc1f57977a2ed8c
https://doi.org/10.4049/jimmunol.153.1.307

Complement-activating ability of leucocytes from patients with complement factor I deficiency

Autor: R. G. Q. Leslie, J M Rasmussen, H. V. Marquart

Previous studies from this laboratory have shown that normal peripheral blood B cells are capable of activating complement via the alternative pathway (AP), that the activation is associated with complement receptor type 2 (CR2) expression, and that

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea69a62ca14947da06dbe85f8266dadc
https://europepmc.org/articles/PMC1364021/

Personalization of thiopurine therapy: Current recommendations and future perspectives.

Autor: Urbančič, Dunja, Pasha, Flaka, Šmid, Alenka, Mlinarič-Raščan, Irena

Publikováno v: Acta Pharmaceutica; Sep2024, Vol. 74 Issue 3, p355-381, 27p

Quantification of C3dg/Epstein-Barr virus receptors on human B cells and B cell lines

Autor: Rasmussen Jm, Jepsen Hh, R Rask, H. V. Marquart, Sven-Erik Svehag

Publikováno v: Complement (Basel, Switzerland). 5(2)

The expression of C3dg/Epstein-Barr virus receptors (CR2) on human peripheral blood and tonsillar B lymphocytes and Raji cells was quantified by measuring binding of unlabeled monoclonal anti-CR2 antibody (OKB7 and HB-5) in an indirect immunoenzymati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3584b568ef3002ed7e3951c68d9e9fce
https://pubmed.ncbi.nlm.nih.gov/2837360